58 research outputs found

    Exploring children’s experiences of NAPLAN: beyond the cacophony of adult debate

    Get PDF

    Educational leadership and the challenge of engaging young people in meaningful learning

    Get PDF
    This chapter presents some innovative educational leadership initiatives and programs designed to support and engage young people in secondary schooling in complex settings. Data from various case studies are shared to demonstrate school-level strategies that help keep students who are in danger of disengaging from education, not only in school but enthused about their learning. In this chapter, we emphasise strategies for school leaders and outline a series of principles for engaging with young people in mainstream school settings that have complex features, including: rural and remote locations; high proportion of students from Indigenous or English as an Additional Language or Dialect backgrounds; low-SES/high-poverty; and drought-affected regions and areas of low employment. We argue for the importance of community connectedness as a core pillar of engaging with young people in meaningful learning, as well as for a variety of deeply contextualised, local practices that best meet the learning needs of students within their local communities

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock

    Get PDF
    Background A variety of epigenetic clocks utilizing DNA methylation changes have been developed; these clocks are either tissue-independent or designed to predict chronological age based on blood or saliva samples. Whether discordant tick rates between tissue-specific and general epigenetic clocks play a role in health and disease has not yet been explored. Results Here we analyze 1941 cervical cytology samples, which contain a mixture of hormone-sensitive cervical epithelial cells and immune cells, and develop the WID general clock (Women’s IDentification of risk), an epigenetic clock that is shared by epithelial and immune cells and optimized for cervical samples. We then develop the WID epithelial clock and WID immune clock, which define epithelial- and immune-specific clocks, respectively. We find that the WID-relative-epithelial-age (WID-REA), defined as the difference between the epithelial and general clocks, is significantly reduced in cervical samples from pre-menopausal women with breast cancer (OR 2.7, 95% CI 1.28-5.72). We find the same effect in normal breast tissue samples from pre-menopausal women at high risk of breast cancer and show that potential risk reducing anti-progesterone drugs can reverse this. In post-menopausal women, this directionality is reversed. Hormone replacement therapy consistently leads to a significantly lower WID-REA in cancer-free women, but not in post-menopausal women with breast or ovarian cancer. Conclusions Our findings imply that there are multiple epigenetic clocks, many of which are tissue-specific, and that the differential tick rate between these clocks may be an informative surrogate measure of disease risk.publishedVersio

    Making every day count: effective strategies to improve student attendance in Queensland state schools

    Get PDF
    The research conducted for this report indicates that schools need to adopt an approach to improving attendance that reflects three important criteria: consistent terminology; comprehensiveness; and concern with high-quality pedagogy and curriculum.\ua0As with the argument in the literature, the data in this report suggest that effective strategies are based on the assumption that every day at school must be made to count. There has to be an educational reason as to why it is critical for students to attend every day. This means that issues of pedagogy and curriculum have to be central to addressing issues of school attendance. The provision of a meaningful education is perhaps the most important contribution that schools can make to enhancing student attendance

    Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

    Get PDF
    Background: Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising progesterone can prevent breast cancers in humans. We suggest that targeting progesterone signalling could be a means of reducing features which are known to promote breast cancer formation. Methods: In healthy premenopausal women with and without a BRCA mutation we studied (i) estrogen and progesterone levels in saliva over an entire menstrual cycle (n = 20); (ii) cancer-free normal breast-tissue from a control population who had no family or personal history of breast cancer and equivalently from BRCA1/2 mutation carriers (n = 28); triple negative breast cancer (TNBC) biopsies and healthy breast tissue taken from sites surrounding the TNBC in the same individuals (n = 14); and biopsies of ER+ve/PR+ve stage T1–T2 cancers and healthy breast tissue taken from sites surrounding the cancer in the same individuals (n = 31); and (iii) DNA methylation and DNA mutations in normal breast tissue (before and after treatment) from clinical trials that assessed the potential preventative effects of vitamins and antiprogestins (mifepristone and ulipristal acetate; n = 44). Results: Daily levels of progesterone were higher throughout the menstrual cycle of BRCA1/2 mutation carriers, raising the prospect of targeting progesterone signalling as a means of cancer risk reduction in this population. Furthermore, breast field cancerization DNA methylation signatures reflective of (i) the mitotic age of normal breast epithelium and (ii) the proportion of luminal progenitor cells were increased in breast cancers, indicating that luminal progenitor cells with elevated replicative age are more prone to malignant transformation. The progesterone receptor antagonist mifepristone reduced both the mitotic age and the proportion of luminal progenitor cells in normal breast tissue of all control women and in 64% of BRCA1/2 mutation carriers. These findings were validated by an alternate progesterone receptor antagonist, ulipristal acetate, which yielded similar results. Importantly, mifepristone reduced both the TP53 mutation frequency as well as the number of TP53 mutations in mitotic-age-responders. Conclusions: These data support the potential usage of antiprogestins for primary prevention of poor-prognostic breast cancers

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    ‘Because then you could never ever get a job!’: children’s constructions of NAPLAN as high-stakes

    No full text
    In the midst of the debate surrounding the question of whether Australia’s National Assessment Program: Literacy and Numeracy (NAPLAN) test is high-stakes, it is evident that children’s own accounts of their experiences remain sparse. This paper describes the findings of a case study which documented the experiences of 105 children across two Catholic primary schools in Queensland serving different socio-economic status (SES) communities. Analysis of the data revealed that these teachers and principals did not experience NAPLAN as high-stakes. However, the data suggested that the children experienced the tests within a confusing context of contradictions and dissonances emanating from multiple sources; receiving little, if any, clear and consistent information regarding the purpose and significance of NAPLAN. While the children’s responses were varied, many reported NAPLAN as a negative experience, with some constructing the test as high-stakes. These constructions ranged from personal judgement or sense of letting their families down, to failure, and less commonly, grade retention and school exclusion. Some Year 3 children had also constructed good results as vital to future prosperity. These constructions bring into question the assumption that because NAPLAN is designed to be a low-stakes test, that children will necessarily experience it in this way

    Exploring children's lived experiences of NAPLAN

    No full text
    This chapter explores how NAPLAN is experienced by children through a study of 105 children's experiences in Queensland Catholic Primary schools serving different socioeconomic status (SES) communities. It suggests, despite the Australian Curriculum, Assessment and Reporting Authority's (ACARA) design of NAPLAN as a low-stakes test, many children's negative responses to NAPLAN point to an experience of NAPLAN as a high-stakes and an alien event. The findings support those of research that suggests NAPLAN impacts significantly on the wellbeing of many primary school-aged children. The children's emotional responses were varied, aligning with international and Australian research that suggests that not all children experience standardised tests as negative events. The focus group discussions suggested that the children's everyday experiences of schooling involved engaging in dialogue with their teachers and peers to consolidate and refine their understandings, regardless of whether tasks were collaborative or individual in nature
    • …
    corecore